The Relationship Between Zinc Deficiency and Infectious Complications in Patients with Hepatitis B Virus-related Acute-on-chronic Liver Failure

Overview

Journal Gastroenterol Rep (Oxf)

Specialty Gastroenterology

Date 2022 Nov 16

PMID 36381223

Authors

Xinhua Li

Lu Wang

Na He

Yeqiong Zhang

Jiahui Pang

Heping Wang

Meng Yu

Yongyu Mei

Liang Peng

Wenxiong Xu

Affiliations

Soon will be listed here.

Abstract

Background: The prevalence of zinc deficiency is high in patients with chronic liver disease, but few studies have hitherto explored the relationship between the serum zinc level and hepatitis B virus (HBV)-related acute-on-chronic liver failure (ACLF). This study aimed to assess the association between zinc deficiency and infectious complications, and model for end-stage liver disease (MELD) score in patients with HBV-related ACLF.

Methods: Patients with HBV-related ACLF from the Department of Infectious Diseases of the Third Affiliated Hospital of Sun Yat-sen University (Guangzhou, China) between January 2019 and December 2019 were retrospectively analysed in this study. Their demographic, clinical, and laboratory data were retrieved from the hospital information system and analysed. The Student's -test was used for normally distributed continuous variables between two groups and the Chi-square test was used for categorical data. Univariate and multivariate logistic regression analyses were applied to identify independent parameters.

Results: A total of 284 patients were included in this study, including 205 liver cirrhosis and 79 non-cirrhosis patients. The proportion of patients with zinc deficiency was the highest (84.5%), followed by subclinical zinc deficiency (14.1%) and normal zinc level (1.4%). Patients in the zinc deficiency group had a higher MELD score than the subclinical zinc deficiency or normal zinc group (=0.021). Age, total bilirubin, and serum zinc level were independent factors for infection (<0.05). The serum zinc level in patients without complications at admission was significantly higher than that in patients with complications (=0.004). Moreover, the serum zinc level in patients with prothrombin time activity (PTA) of <20% was significantly lower than that in patients with 20%≤PTA<30% (=0.007) and that in patients with 30%≤PTA<40% (<0.001).

Conclusions: Zinc deficiency is common in patients with HBV-related ACLF. Zinc deficiency is closely associated with infectious complications and MELD score in patients with HBV-related ACLF.

Citing Articles

Bacterial Infections in Acute-on-chronic Liver Failure: Epidemiology, Diagnosis, Pathogenesis, and Management.

Xu Z, Zhang X, Chen J, Shi Y, Ji S J Clin Transl Hepatol. 2024; 12(7):667-676.

PMID: 38993512 PMC: 11233977. DOI: 10.14218/JCTH.2024.00137.

Comparative analysis of monocyte-derived dendritic cell phenotype and T cell stimulatory function in patients with acute-on-chronic liver failure with different clinical parameters.

Wu Z, Shi H, Zhang L, Shi H, Miao X, Chen L Front Immunol. 2023; 14:1290445.

PMID: 38111573 PMC: 10725902. DOI: 10.3389/fimmu.2023.1290445.

References

Hernaez R, Patel A, Jackson L, Braun U, Walling A, Rosen H . Considerations for Prognosis, Goals of Care, and Specialty Palliative Care for Hospitalized Patients With Acute-on-Chronic Liver Failure. Hepatology. 2020; 72(3):1109-1116. DOI: 10.1002/hep.31316. View

Shigefuku R, Iwasa M, Katayama K, Eguchi A, Kawaguchi T, Shiraishi K . Hypozincemia is associated with human hepatocarcinogenesis in hepatitis C virus-related liver cirrhosis. Hepatol Res. 2019; 49(10):1127-1135. DOI: 10.1111/hepr.13388. View

Sarin S, Choudhury A, Sharma M, Maiwall R, Al Mahtab M, Rahman S . Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update. Hepatol Int. 2019; 13(4):353-390. PMC: 6728300. DOI: 10.1007/s12072-019-09946-3. View

Besecker B, Exline M, Hollyfield J, Phillips G, DiSilvestro R, Wewers M . A comparison of zinc metabolism, inflammation, and disease severity in critically ill infected and noninfected adults early after intensive care unit admission. Am J Clin Nutr. 2011; 93(6):1356-64. PMC: 3095505. DOI: 10.3945/ajcn.110.008417. View

Loomba V, Pawar G, Dhar K, Setia M . Serum zinc levels in hepatic encephalopathy. Indian J Gastroenterol. 1995; 14(2):51-3. View

Camarata M, Ala A, Schilsky M . Zinc Maintenance Therapy for Wilson Disease: A Comparison Between Zinc Acetate and Alternative Zinc Preparations. Hepatol Commun. 2019; 3(8):1151-1158. PMC: 6671772. DOI: 10.1002/hep4.1384. View

Chen J, Weng W, Huang M, Peng X, He J, Zhang J . Derivation and Validation of a Nomogram for Predicting 90-Day Survival in Patients With HBV-Related Acute-on-Chronic Liver Failure. Front Med (Lausanne). 2021; 8:692669. PMC: 8241917. DOI: 10.3389/fmed.2021.692669. View

. [Guideline for diagnosis and treatment of liver failure]. Zhonghua Gan Zang Bing Za Zhi. 2019; 27(1):18-26. DOI: 10.3760/cma.j.issn.1007-3418.2019.01.006. View

Wessels I, Maywald M, Rink L . Zinc as a Gatekeeper of Immune Function. Nutrients. 2017; 9(12). PMC: 5748737. DOI: 10.3390/nu9121286. View

10.

Overbeck S, Rink L, Haase H . Modulating the immune response by oral zinc supplementation: a single approach for multiple diseases. Arch Immunol Ther Exp (Warsz). 2008; 56(1):15-30. PMC: 7079749. DOI: 10.1007/s00005-008-0003-8. View

11.

Ozbal E, Helvaci M, Kasirga E, Akdenizoglu F, Kizilgunesler A . Serum zinc as a factor predicting response to interferon-alpha2b therapy in children with chronic hepatitis B. Biol Trace Elem Res. 2003; 90(1-3):31-8. DOI: 10.1385/BTER:90:1-3:31. View

12.

Stamoulis I, Kouraklis G, Theocharis S . Zinc and the liver: an active interaction. Dig Dis Sci. 2007; 52(7):1595-612. DOI: 10.1007/s10620-006-9462-0. View

13.

Gammoh N, Rink L . Zinc in Infection and Inflammation. Nutrients. 2017; 9(6). PMC: 5490603. DOI: 10.3390/nu9060624. View

14.

Kamath P, Wiesner R, Malinchoc M, Kremers W, Therneau T, Kosberg C . A model to predict survival in patients with end-stage liver disease. Hepatology. 2001; 33(2):464-70. DOI: 10.1053/jhep.2001.22172. View

15.

Li J, Liang X, You S, Feng T, Zhou X, Zhu B . Development and validation of a new prognostic score for hepatitis B virus-related acute-on-chronic liver failure. J Hepatol. 2021; 75(5):1104-1115. DOI: 10.1016/j.jhep.2021.05.026. View

16.

Hernaez R, Sola E, Moreau R, Gines P . Acute-on-chronic liver failure: an update. Gut. 2017; 66(3):541-553. PMC: 5534763. DOI: 10.1136/gutjnl-2016-312670. View

17.

Mocchegiani E, Giacconi R, Muzzioli M, Cipriano C . Zinc, infections and immunosenescence. Mech Ageing Dev. 2001; 121(1-3):21-35. PMC: 7126297. DOI: 10.1016/s0047-6374(00)00194-9. View

18.

Nishikawa H, Enomoto H, Yoh K, Iwata Y, Sakai Y, Kishino K . Serum Zinc Level Classification System: Usefulness in Patients with Liver Cirrhosis. J Clin Med. 2019; 8(12). PMC: 6947237. DOI: 10.3390/jcm8122057. View

19.

Ko W, Guo C, Hsu G, Chiou Y, Yeh M, Yaun S . The effect of zinc supplementation on the treatment of chronic hepatitis C patients with interferon and ribavirin. Clin Biochem. 2005; 38(7):614-20. DOI: 10.1016/j.clinbiochem.2005.04.003. View

20.

Souffriau J, Timmermans S, Vanderhaeghen T, Wallaeys C, Van Looveren K, Aelbrecht L . Zinc inhibits lethal inflammatory shock by preventing microbe-induced interferon signature in intestinal epithelium. EMBO Mol Med. 2020; 12(10):e11917. PMC: 7539219. DOI: 10.15252/emmm.201911917. View